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Abstract
Despite intensive effort, the majority of the annotated Mycobacterium tuberculosis genome consists of genes encoding
proteins of unknown or poorly understood function. For example, there are seven conserved hypothetical proteins
annotated as homologs of pyridoxine 59-phosphate oxidase (PNPOx), an enzyme that oxidizes pyridoxine 59-phosphate
(PNP) or pyridoxamine 59-phosphate (PMP) to form pyridoxal 59-phosphate (PLP). We have characterized the function of
Rv2607 from Mycobacterium tuberculosis H37Rv and shown that it encodes a PNPOx that oxidizes PNP to PLP. The kcat and
KM for this reaction were 0.01 s
21 and 360 mM, respectively. Unlike many PNPOx enzymes, Rv2607 does not recognize PMP
as a substrate.
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Introduction
A large fraction of the Mycobacterium tuberculosis (Mtb) genome
encodes proteins of unknown or putative function based on
sequence homology to other characterized proteins [1]. This
knowledge gap poses a significant challenge to efforts to
understand the complete biological repertoire of this deadly
pathogen. While bioinformatics provides useful clues about gene
function, biochemical characterization of gene products remains
essential to accurate annotation, particularly in cases where
apparent functional redundancy is suggested based upon the
presence of multiple homologous proteins. For example, a number
of enzymes involved in vitamin B6 metabolic pathways remain
uncharacterized, despite the important role this vitamin plays in
Mtb metabolism. The term ‘vitamin B6’ collectively refers to
pyridoxine 59-phosphate (PNP) (1), pyridoxal 59-phosphate (PLP)
(2), pyridoxamine 59-phosphate (PMP) (3), and their respective
non-phosphorylated forms [2]. PLP biosynthesis is required for
Mtb survival and virulence in vivo and it is a predicted cofactor to a
number of enzymes essential to Mtb growth [3]. Therefore,
vitamin B6 biosynthesis and salvage may be attractive target
pathways for the development of novel compounds with anti-
tuberculosis activity.
In both prokaryotic and eukaryotic organisms, pyridoxine 59-
phosphate oxidase (PNPOx) is a flavin mononucleotide (FMN)-
dependent enzyme encoded by the gene pdxH that produces PLP
by oxidizing either PNP or PMP [4] (Figure 1). In Escherichia coli,
PNPOx catalyzes the last step in the deoxyxyulose 59-phosphate
(DXP)-dependent biosynthetic pathway to PLP [2]. Most
prokaryotes and plants biosynthesize PLP via an alternative
route called the DXP-independent pathway [5] (Figure 1). The
DXP-independent pathway includes PLP synthase, a macromo-
lecular complex consisting of enzymes encoded by the genes pdx1
and pdx2 [2]. This complex is capable of carrying out de novo PLP
biosynthesis directly. The Mtb genome encodes homologs of
proteins involved in the DXP-independent PLP biosynthetic
pathway, pdx1 (Rv2606c) and pdx2 (Rv2604c), but lacks the genes
for enzymes in the DXP-dependent pathway [6]. It has been
demonstrated that Mtb synthesizes PLP via the DXP-independent
pathway using PLP synthase and that disruption of the pdx1 gene
generates a vitamin B6 auxotrophic Mtb mutant [3]. Organisms
with genes that encode both PLP synthase and PNPOx probably
only use the oxidase to salvage PLP after it participates as a
cofactor in enzymatic reactions. It is unclear whether Mtb can
acquire PLP or other B6 vitamers from the host [3].
The Mtb genome contains a gene for a putative PNPOx,
Rv2607, annotated as pdxH (Cole 1998). Gene expression for
rv2607 (pdxH) has been detected in over 300 different experimental
conditions in vitro ([7]; www.tbdb.org/expressionHistory.
shtml?gn=Rv2607) as well as in macrophages [8]. Expression of
this gene is upregulated by stresses such as exposure of Mtb to
certain inhibitors of translation as well as by nitroimidazoles such
as PA-824 [7]. Intriguingly, the Mtb genome encodes six gene
products in addition to Rv2607 that are also annotated as PNPOx
or ‘‘PNPOx-like’’ proteins and they have unknown function
(Table 1). The PNPOx-like proteins (Rv1155, Rv2991, Rv2074,
Rv1875, Rv3369, Rv0121c) appear to share global topology
similarity with Rv2607, but display low overall sequence similarity
(less than 25%). Rv2607 is the most highly conserved in this
protein family across other mycobacterial species, including in the
reduced genome of M. leprae, and it has the highest homology to
the PNPOxs of Streptomyces coelicolor and Saccharomyces cerevisiae. It is,
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27643therefore, the most logical candidate for the canonical PNPOx of
Mtb.
The crystal structure of Rv2607 has been solved to 2.5 A ˚
resolution [9]. The proposed active site of Rv2607 is very similar
to that of PNPOx homologs in other organisms. Residues known
to be important for PLP binding in the E. coli and human PNPOx
are nearly all conserved in Rv2607 (Figure S3) and a structural
superimposition of the E. coli PNPOx and Rv2607 reveals a low
RMSD of 0.8 A ˚ for alpha carbons in the PLP binding region of
the active site [9] (Figure S4). Although FMN could not be
definitively placed in the Mtb PNPOx active site (electron density
for the FMN cofactor is weak in the Rv2607 crystal structure), the
residues known to interact with FMN in the E. coli and human
PNPOx enzymes were found to be conserved in Rv2607 [9].
Results and Discussion
To test the hypothesis that Rv2607 is a PNPOx, we
heterologously overexpressed in BL21(DE3) E. coli cells and
purified the amino-terminal 6x-histidine tag fusion protein. SDS-
PAGE analysis showed that the protein was purified to .95%
homogeneity and the yield of the purified protein was 140 mg per
liter of cells, as determined using the Bradford test [10].
The purified protein was bright yellow in color, suggesting the
presence of a co-purified cofactor. The yellow cofactor bound
tightly to Rv2607 as purified and was unambiguously identified as
FMN (m/z 457.2 Da) by nanoflow electrospray ionization mass
spectrometry (nESI-MS) after it was isolated from the heat-
denatured protein (Figure S1). Intact Rv2607 analyzed by nESI-
MS reveals it exists in a predominantly dimeric oligomerization
state (Figure 2), which is consistent with other known PNPOxs [4].
This data, in combination with circular dichroism analysis,
indicates that the freshly purified protein is functionally folded.
Although two FMN binding sites exist at the homodimer interface
of Rv2607, only one FMN molecule per dimer is present in the
protein as purified (Figure 2). A 2:1 ratio of PNPOx protomer to
FMN has been reported for other PNPOxs [11], [12], [13].
Two major protein bands were observed by SDS-PAGE, one
corresponding to the Rv2607 monomer (,27 kDa) and the other
corresponding to a homodimer (,54 kDa). The identity of the
band corresponding to 54 kDa was confirmed as Rv2607 by MS
analysis. In order to investigate the stability of the dimer, the
charge state 14+ of Rv2607 was isolated in a tandem MS
experiment (MS/MS) and submitted to collision-induced dissoci-
ation (CID). The MS/MS spectrum (Figure S2) shows that
dissociation begins to occur at accelerating voltages of 150 V (trap)
and 110 V (transfer). High accelerating voltages were required to
induce dissociation of this very stable Rv2607 homodimer. Small
populations of both monomers are visible at high and low m/z
respectively and several additional peaks in the spectrum indicate
that such high voltages also cause fragmentation of the protein,
which has been previously reported for a different system [14].
This result is consistent with the crystal structure of Rv2607, which
Figure 1. PLP formation catalyzed by PNPOx and associated vitamin B6 metabolic pathways. The role of Rv2607 is shown in red. In E.
coli, PNPOx catalyzes the last step in the DXP-dependent PLP biosynthetic pathway [2]. Most organisms capable of PLP biosynthesis produce PLP via
PLP synthase, a macromolecular complex consisting of Pdx1 and Pdx2 [2]. Organisms with genes that encode both PLP synthase and PNPOx likely use
PNPOx to salavage PLP from PNP and PMP, which are produced by enzymes that use PLP as a cofactor.
doi:10.1371/journal.pone.0027643.g001
Table 1. Summary of NCBI gene annotations for PNPOx-like
proteins in selected organisms that contain pdx1 and pdx2
and the role of PNPOx is considered to be for PLP salvage.
M. tuberculosis
M.
smegmatis PI
M.
leprae PI
S.
coelicolor PI
Rv2607 (PNPOx) pdxH (69%) pdxH (67%) SCO4387 (44%)
Rv1155
(PNPOx-like)
MSMEG_
5170
(80%) ML1508 (88%) SCO5312 (57%)
Rv2991
(PNPOx-like)
MSMEG_
0048
(73%) – SCO1357 (38%)
Rv2074
(PNPOx-like)
MSMEG_
3880
(85%) – SCO0838 (53%)
Rv0121c
(PNPOx-like)
MSMEG_
6526
(59%) – –
Rv1875
(PNPOx-like)
MSMEG_
6576
(35%) – –
Rv3369
(PNPOx-like)
–– –
Homologs were assigned using protein basic local alignment search tool
(pBLAST) [26] for sequence alignments with E-values below 10
26. Percent
identity (PI) is shown to the right of each gene annotation, which has been
calculated by dividing the number of identical residues by the length of the
alignment.
doi:10.1371/journal.pone.0027643.t001
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each other and the dimer interface consists of about 20% of the
total protomer surface [9].
Rv2607-mediated catalysis of PLP formation was examined by
LC-MS (Figure 3A). To resolve the product, PLP, from the
substrates, PNP and PMP, PLP was derivatized with 2,4-
dinitrophenylhydrazine (DNPH) to form a PLP-DNP hydrazone.
It has been previously reported that PLP readily forms a stable
hydrazone with phenylhydrazine [15]. DNP hydrazones are not
formed with either PNP or PMP because they lack a reactive
aldehyde. A peak corresponding to the chemically-synthesized
PLP-DNP hydrazone (retention time = 7.60 min) was detected in
the enzymatic reaction of Rv2607 with PNP. Electrospray
ionization in the positive mode confirmed it to be the DNP
hydrazone of PLP (m/z=428). No such peak was observed in the
enzyme and substrate (PNP) negative controls, however, a peak
was observed in the absence of added FMN since the enzyme co-
purified with FMN. The PLP-DNP hydrazone was not detected
when PMP was tested as a substrate (Figure 3A). To eliminate the
possibility that the PLP formation observed is due to the presence
of contaminating indigenous E.coli PNPOx, we tested E.coli
Bl21(DE3) cell lysates for PNPOx activity and showed that PLP
can only be detected when Rv2607 is overexpressed. We also
conducted PNPOx activity assays using an inactive PNPOx-like
His6x-tagged protein expressed and purified in the same manner as
was Rv2607 and did not detect PLP production. These data
confirm that the observed PNP turnover is solely due to Rv2607.
Further, E. coli PNPOx demonstrates PMP turnover [4], while
Rv2607 does not.
Rv2607-catalyzed formation of PLP was also observed directly
by
1H NMR spectroscopy in the presence of Rv2607 and PNP
over time (Figure 3B). Increasing signals corresponding to the
C2-
1H and the aldehyde proton of PLP were observed with time
with a concurrent decrease in signal from the C2-
1H of PNP.
Under these experimental conditions, there was 75% conversion
of the substrate after 18 hours (Figure 3B). Spiking the reaction
mixture with a synthetic standard of PLP confirmed that the
observed chemical shifts in the reaction mixture correspond to
PLP.
Rv2607-catalyzed PNP oxidation exhibited Michaelis-Menten
kinetics with a kcat and KM of 0.01 s
21 and 360 mM respectively
(Figure 3C). The reported kcat and KM for the E. coli enzyme and
PNP are 0.2-0.8 s
21 and 2 mM, respectively [16], [17] and the kcat
and KM for the human enzyme with PNP is 0.19 s
21 and 1.8 mM,
respectively [18]. While both the E. coli and human PNPOx
recognize PMP as a substrate, significant PLP formation was not
seen when PMP was tested as a substrate for Rv2607. To our
knowledge, Rv2607 is the first example of a PNPOx that does not
oxidize PMP to PLP. The biological implication of the kinetic
differences between Rv2607 and other PNPOxs is not yet known.
It may be that Rv2607 exhibits a relatively low catalytic efficiency
because it is not directly involved in the biosynthesis of PLP (as is
the E. coli PNPOx) and unlike the human PNPOx, it is operating
in a cellular environment which possesses the machinery for de novo
PLP biosynthesis.
Although the Mtb protein encoded by Rv2607 was annotated
as a member of the PNPOx family based on sequence alignment,
biochemical data to support this classification had not been
Figure 2. Nano-ESI mass spectrum of intact Rv2607 with co-purified FMN. The major species, C, has peaks with charges ranging from 15+ to
12+ in the 3500-4500 m/z range that correspond to a molecular weight of 55376612. This experimental mass is consistent with the calculated mass
for the complex of dimeric Rv2607 with one molecule of FMN bound (55442 Da), which is derived from the amino acid sequence of the 6x-histidine
tagged Rv2607 (54986 Da; 27493 Da per protomer) and the molecular weight of FMN (456 Da). Monomeric tagged Rv2607 and truncated Rv2607
monomer (missing 10-11 residues), are present in solution and correspond to molecular weights of A (27450652 Da) and B (26215654 Da)
respectively. A minor dimeric species comprised of full length and truncated monomer is represented as species D. Higher molecular weight
oligomers (trimers E and tetramers F with molecular weights of 110.6 and 82.7 kDa, respectively) are electrospray-induced non-specific association of
monomers and dimers.
doi:10.1371/journal.pone.0027643.g002
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eukaryotic sources (pig [11] and sheep [12] brain, rabbit liver
[19], recombinant E. coli [16], recombinant human [18]) are
reported to catalyze the oxidation of PNP as well as PMP to form
PLP. We have found that Rv2607 catalyzes the oxidation of PNP,
but not PMP, in the presence of FMN. Many organisms that are
capable of de novo PLP biosynthesis possess homologs to PNPOx
(Table 1), although there are exceptions, including Bacillius
subtillis. The genomes of several microorganisms, including that of
Mtb and other mycobacteria, include genes that encode for
proteins structurally related to PNPOx and are annotated as
‘PNPOx-like proteins’. Very little is known about the function of
these proteins. PNPOx-like proteins may have redundant PNPOx
function or they may have evolved a new, as yet unknown
function.
Materials and Methods
Overexpression and purification
The clone of Rv2607 was obtained as an amino-terminal 6x-
histidine tag fusion construct with thrombin cleavage site in a
modified pET28b vector from the laboratory of Dr. Thomas C.
Terwilliger, Los Alamos National Laboratories, New Mexico,
USA [9]. The construct also included a kanamycin resistance gene
for selection. Rv2607 was transformed in Escherichia coli BL21-
Gold(DE3) cells (Stratagene). An overnight culture of a single
colony grown at 37uC with agitation was diluted 1:100 into
500 mL Luria Broth (LB) supplemented with 40 mg/mL kanamy-
cin. The culture was incubated at 37uC with shaking. Protein
expression was induced when the culture reached an OD600nm of
0.6 with the addition of isopropyl thiogalactopyranoside (IPTG) to
Figure 3. Reverse-phase HPLC, NMR, and spectrophotometric analysis of the PNPOx activity of Rv2607. (A) HPLC chromatograms
(270 nm) of reaction mixtures containing PNP (i-iv) or PMP (v-viii), FMN, and Rv2607, and the associated control reactions. All reactions were carried
out in 25 mM potassium phosphate buffer (pH 7.8), incubated at 25uC for 3 h, and quenched with DNPH (0.7 mM final concentration). Where
present, the reaction components were at the following concentrations: 1 mM PNP or PMP, 10 mM FMN, and 10 mM Rv2607. Reaction mixtures
contained: (i) PNP, FMN, and Rv2607, (ii) PNP and FMN (enzyme negative control), (iii) PNP and Rv2607 (no added FMN), (iv) FMN and Rv2607
(substrate negative control), (v) PMP, FMN, and Rv2607, (vi) PMP and FMN (enzyme negative control), (vii) PMP and Rv2607 (no added FMN), (viii) FMN
and Rv2607 (substrate negative control). The peak to the right of PLP-DNPH is DNPH, which has a retention time of 8.6 min. (B)
1H NMR analysis of the
conversion of PNP into PLP with time. The enzymatic reaction (1 mM PNP, 28 mM enzyme, 10% D2O in 25 mM potassium phosphate buffer, pH 7.8)
was incubated for 18 hours at 298 K in the spectrometer. Left; stacked
1H NMR spectra recorded at various time points and after the addition of
authentic PLP. The starred peak corresponds to PLP hydrate. Right; a plot of percent substrate conversion versus time. Substrate conversion was
determined by comparing integrals of the C2-
1H signals associated with PLP (7.80 ppm) to that of PNP (7.75 ppm). (C) Michaelis-Menten plot for
Rv2607 with PNP as a substrate. The rate of PLP formation was monitored spectrophotometrically (lmax = 388 nm, e=4900 cm
21M
21) for various
concentrations of PNP. All solutions were made in 100 mM potassium phosphate buffer (pH 7.8).
doi:10.1371/journal.pone.0027643.g003
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at 20uC for 20 h with agitation. Cells were harvested by
centrifugation (14000x g, 15 min). The bright yellow cell pellet
was resuspended in 20 mM Tris-HCl, 100 mM NaCl, pH 8.0.
The cells underwent one freeze-thaw cycle (280uC) and were
further lysed by sonication (Misonix S-4000, amplitude 60%, 1 s
on, 1 s off for 30 s, repeated 3 times). The cell lysate was
centrifuged (48,000 x g, 30 min) and the clarified yellow
supernatant was applied to a Ni-NTA affinity column (5 mL)
pre-equilibrated with buffer A (20 mM Tris-HCl, 100 mM NaCl,
20 mM imidazole, pH 8.0). The column was washed with buffer A
(150 mL) until the flow through no longer contained any protein,
as determined by a Bradford test [10]. The protein was eluted with
buffer B (20 mM Tris-HCl, 500 mM NaCl, 300 mM imidazole,
pH 8.0). The eluted protein was buffer exchanged into phosphate
buffered saline (PBS) (pH 7.6) containing 10% glycerol using
Vivaspin 20 10 kDa molecular weight cut off centrifugal filters.
SDS-PAGE analysis showed that the protein was purified to
.95% homogeneity and the yield of the purified protein was
determined to be 140 mg per liter of cells with the Bradford assay.
Synthesis of PNP
PNP was synthesized based on a published procedure [20] with
some modifications. Under argon atmosphere, freshly prepared
0.5 M NaOH (3.2 mL) was added to PLP (200 mg, 0.8 mmol).
The solution was deoxygenated by bubbling with argon for 5 min
at room temperature, after which sodium borohydride (12 mg,
0.32 mmol) was added portionwise with stirring. The reaction was
stirred until complete as judged by TLC (SiO2, 80:20 methanol:
ethyl acetate v:v). The reaction was quenched with acetone
(120 mL, 1.6 mmol) and allowed to stir at room temperature for
30 min, after which NaOH (147 mg, 3.7 mmol) was added. After
stirring for another 15 min at room temperature, the reaction
mixture was loaded directly onto a column containing 5 mL
Amberlite IRA-743 (5 mL in a 1.0611.0 cm column) to remove
borate salts. The resin had been conditioned by washing with
absolute ethanol (25 mL), water (3625 mL), 1 M HCl (25 mL),
water (25 mL), 1 M NaOH (25 mL), and finally equilibrated with
water (50 mL). The flow through was collected and the resin was
washed with enough water (5-7 mL) so that PNP could no longer
be detected spectrophotometrically (lmax = 325 nm at pH 7.5).
The flow-through and wash were pooled and this solution was
further purified with weakly acidic cation exchange resin
Amberlite IRC-76 (10 mL in a 1.30612.5 cm column). The resin
had been conditioned with 1 M NaOH (50 mL), water (50 mL),
1 M HCl (50 mL), and finally equilibrated with water (100 mL).
The flow through was collected and pooled with two elution steps:
0.5 M NaOH (5 mL) and water (10 mL). The resin was washed
with water (10 ml) until PNP could not be detected spectropho-
tometrically. The eluted product was pooled, lyophilized, and
resuspended in 100 mM potassium phosphate buffer, pH 7.8.
1H
NMR (D2O, 400 MHz): d 7.77 (1H, s), 4.88 (2H, d, J=6.9), 4.77
(2H, s), 2.41 (3H, s).
Formation of dinitrophenylhydrazone of PLP
Dinitrophenylhydrazine (DNPH) reactivity with PLP, PNP, and
PMP was tested. To 1 mM solutions of PLP (100 mL), PNP
(100 mL), and PMP (100 mL) in 25 mM potassium phosphate
buffer (pH 7.8) a saturated solution of DNPH in 3 M HCl (10 mL)
was added to a final concentration of 0.7 mM. As a negative
control, 3 M HCl (10 mL) was substituted for DNPH. The PLP,
PNP and PMP negative control reactions were carried out by
substituting the substrate with 100 mL of 25 mM potassium
phosphate buffer (pH 7.8). All reactions were carried out at
25uC for 3 h.
Assay for Rv2607-dependent PLP formation
Reaction mixtures (150 mL each) containing 1 mM PNP or
1 mM PMP (Figure 2), 10 mM FMN, and 10 mM freshly purified
Rv2607 in 25 mM potassium phosphate buffer were incubated at
25uC for 3 h. Enzyme, cofactor, and substrate negative control
reactions were treated in a similar manner. After 3 h incubation at
25uC, the reaction was quenched with addition of 10 ml of DNPH
in 3 M HCl to a final concentration of 0.7 mM. The reaction
mixture was filtered with 10 kDa MW cutoff centrifugation filters
and 10 ml of the reaction was analyzed by LC-MS.
LC-MS analysis
Analysis of the enzymatic reactions and controls were
performed on Agilent 1100 LC-MS instrument using Luna
(3 mm) C18 column (5062 mm, Phenomenex). Solution A
contained water and 0.1% formic acid. Solution B contained
acetonitrile and 0.1% formic acid. The column was equilibrated
with 95% solution A for 1 min. The following gradient was used:
5% to 95% solution B from 1 to 11 min; 95% solution B from 11
to 15 min; 95% to 5% solution B from 15 to 17 min; 5% solution
B from 17 to 21.5 min.
NMR time-course
The enzymatic reaction was monitored by
1H NMR spectros-
copy using a Bruker Avance 700 MHz spectrometer with a TXI
cryoprobe. The reaction mixture contained 1 mM PNP, 10%
deuterium oxide, and 20 mM 2,2,3,3-D4-3-(trimethylsilyl)propio-
nic acid (TSP) as an internal standard in 25 mM potassium
phosphate buffer (pH 7.6). The reaction was initiated with the
addition of freshly purified enzyme to a final concentration of
28 mM or an equivalent volume of buffer for the control. The
enzymatic reaction and enzyme negative control (200 mL) were
added to 3 mm capillary tubes (Bruker), which were maintained at
constant temperature (25uC). The spectrometer conditions were
optimized with the enzyme negative control sample. The sample
was locked, shimmed, and the pulses were calibrated for water
suppression using excitation sculpting with gradients [21].
1H
NMR spectra were collected at selected time points for 18 hours
(Figure 3). Each experiment consisted of 4 dummy scans followed
by 8 collected scans, resulting in 63 s of acquisition time per data
point. Chemical shifts are reported in ppm relative to TSP
(d=0 ppm). The spectra were processed and analyzed using
TopSpin
TM 1.8 (Bruker, Billerica, Massachusetts, USA). Substrate
conversion was determined by comparing integrals of the C2-
1H
signals associated with PLP (7.80 ppm) to that of PNP (7.75 ppm)
(Figure 3B). To confirm the identity of the product formed, the
reaction mixture was enriched with authentic PLP after 18 hours.
Steady state kinetic parameters
The rate of product formation was monitored spectrophoto-
metrically with a Varian Cary 400 UV/Vis spectrophotometer.
The product, PLP, has a lmax at 388 nm and an extinction
coefficient of 4900 cm
21M
21 [22]. The rate of PLP production
was measured for various concentrations of PNP: 50 mM, 100 mM,
175 mM, 250 mM, 500 mM, 750 mM, 1000 mM, 1500 mM. Freshly
purified enzyme was added to each reaction mixture and no
exogenous FMN was added. All solutions were made in 100 mM
potassium phosphate buffer (pH 7.8). The KM and kcat for Rv2607
were determined by fitting the initial rate (less than 10%
conversion) of product formation as a function of substrate
Biochemical Characterization of Rv2607
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regression using GraphPad Prism 5 (GraphPad Software, Inc., La
Jolla, California, USA) (Figure S1).
Mass spectrometry
Nanoflow electrospray ionization mass spectra (nESI-MS) were
recorded on a Synapt HDMS system optimized for the
transmission of noncovalent complexes [23]. Typically, 2.5 mL
solutions containing Rv2607 in 100 mM ammonium acetate were
electrosprayed from gold-coated glass capillaries [24]. To preserve
the non-covalent interactions in the Rv2607 dimer in complex
with FMN, the MS parameters used for the Synapt were: capillary
voltage, 1.7 kV; sample cone, 80–100 V; trap and transfer
collision energy, 15V and 12 V respectively; backing pressure
3.8 mbar; trap and IMS pressure 5e
22 and 5e
21 mbar, respec-
tively; time-of-flight analyzer pressure 1.16e
26 mbar. For the CID
experiment, the ‘‘trap and transfer collision energies’’ were 150 V
and 110 V respectively to effect dissociation. Extracted cofactor
from Rv2607 and authentic FMN were analyzed with a Q Star
Elite Mass Spectrometer (Applied Biosystems/MDS Sciex) by
electrospray ionization positive ion mode with a gold-plated
nanospray tip (Figure S1). To extract the bound cofactor from
Rv2607, a concentrated solution of purified Rv2607 (270 mM) in
25 mM potassium phosphate buffer (pH 7.8) was heat-denatured
for 5 min at 100uC. To the denatured protein was added 300 mL
25 mM potassium phosphate buffer (pH 7.8) and the mixture was
filtered using a 10 K molecular weight cutoff Vivaspin 500
centrifugation filter (15 min at 17,900 xg ) . The flow through was
desalted with C18 Zip TipH pipette tips previously washed with
acetonitrile and equilibrated with 0.1% trifluoroacetic acid (TFA)
in ultrapure water. The analyte was eluted in a solution of
acetonitrile and 0.05% TFA. The FMN standard sample was
acidified in 0.1% TFA to a final concentration of 500 mM. All
spectra were calibrated internally using a solution of cesium iodide
(100 mg/mL). Data were processed with MassLynx 4.0 software
(Waters/Micromass).
Supporting Information
Figure S1 Identification of cofactor bound to Rv2607 by
electrospray ionization mass spectrometry. Cofactor was extracted
from Rv2607 by heat denaturation. FMN has a molecular weight
of 456.2 Da.
(TIF)
Figure S2 MS/MS spectra of Rv2607 homodimer. The isolated
precursor ion, charge state 14+ of the dimeric Rv2607 complex
was submitted to CID with accelerating voltages 150 V (Trap) and
110 V (Transfer). Low populations of charge-state series A and B
corresponding to monomers with measured masses 27362 Da
(monomer, high m/z region) and 27353 Da (low m/z region)
begins to occur at these high voltages. High accelerating voltages
also caused fragmentation of the protein, indicated by a few
unassigned peaks at the low and high m/z region.
(TIF)
Figure S3 Protein sequence alignment of Rv2607 and E. coli
PNPOx. Residues highlighted in red are highly conserved motifs
in PNPOxs [25]. The arrow points to a key difference in the E. coli
PNPOx and Rv2607 sequence that results in greater solvent-
exposure of the active site in Rv2607.
(TIF)
Figure S4 Structural and mechanistic analysis of Rv2607-
catlyzed oxidation of PNP to PLP. (A) Superimposition of the
active site residues of Rv2607 (yellow, PDB ID: 2A2J) and E. coli
PNPOx (grey, PDB ID: 1G77). Labeled residues correspond to
Rv2607. PLP and FMN are present in the E. coli PNPOx structure
only. (B) Proposed mechanism for the oxidation of PNP. A hydride
is transferred from PNP to FMN and oxidized FMN is regenerated
with molecular oxygen.
(TIF)
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